上海医药(601607)l经营稳中有进,费用把控能力强公司发布2025年中报:2025H1营业收入1415.93亿元(+1.56%),其中:医药工业实现销售收入121.60亿元(-4.50%);医药商业实现销售收入1,294.33亿元(+2.17%)。归母净利润44.59亿元(+51.56%),其中:工业板块贡献利润11.50亿元,商业板块贡献利润17.94亿元,主要参股企业贡献利润3.38亿元。...
Source Link上海医药(601607)l经营稳中有进,费用把控能力强公司发布2025年中报:2025H1营业收入1415.93亿元(+1.56%),其中:医药工业实现销售收入121.60亿元(-4.50%);医药商业实现销售收入1,294.33亿元(+2.17%)。归母净利润44.59亿元(+51.56%),其中:工业板块贡献利润11.50亿元,商业板块贡献利润17.94亿元,主要参股企业贡献利润3.38亿元。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.